Thermo Fisher Scientific is the first company to receive US Food and Drug Administration clearance for a blood test to assess a mother’s risk of severe preeclampsia, the leading cause of pregnancy-related illness and death in the US.
The FDA clearance of these breakthrough biomarkers will have a significant impact on prognosis and treatment for thousands of women...